Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Compound Heterozygous Mutations of LIG4 Gene in an Indian LIG4 Syndrome Patient with Severe Microcephaly: Case Report, In-silico Analysis and Systematic Review. | Curr Pediatr Rev | 2025 | 38591195 | PubTator, text mining | PubMed |
| FET fusion oncoproteins disrupt physiologic DNA repair and create a targetable opportunity for ATR inhibitor therapy. | bioRxiv | 2025 | 37205599 | PubTator, text mining | PubMed |
| CRISPR-Cas9-mediated homology-directed repair for precise gene editing. | Mol Ther Nucleic Acids | 2024 | 39494147 | PubTator, text mining | PubMed |
| Crosstalk between BER and NHEJ in XRCC4-Deficient Cells Depending on hTERT Overexpression. | Int J Mol Sci | 2024 | 39408734 | PubTator, text mining | PubMed |
| Negative feedback loop in the activation of non-homologous end joining DNA repair pathway in Helicobacter pylori infected patients with gastritis. | Sci Rep | 2024 | 39375425 | PubTator, text mining | PubMed |
| RAD52-mediated repair of DNA double-stranded breaks at inactive centromeres leads to subsequent apoptotic cell death. | Nucleic Acids Res | 2024 | 39360606 | PubTator, text mining | PubMed |
| Boosting CRISPR-Cas9 efficiency through enhanced homologous recombination. | Mol Ther Nucleic Acids | 2024 | 39329147 | PubTator, text mining | PubMed |
| NEDD4L affects KLF5 stability through ubiquitination to control ferroptosis and radiotherapy resistance in oesophageal squamous cell carcinoma. | J Cell Mol Med | 2024 | 39317954 | PubTator, text mining | PubMed |
| From rest to repair: Safeguarding genomic integrity in quiescent cells. | DNA Repair (Amst) | 2024 | 39167890 | PubTator, text mining | PubMed |
| Synergistic combination of RAD51-SCR7 improves CRISPR-Cas9 genome editing efficiency by preventing R-loop accumulation. | Mol Ther Nucleic Acids | 2024 | 39161621 | PubTator, text mining | PubMed |
| Critical residues in the Ku70 von Willebrand A domain mediate Ku interaction with the LigIV-XRCC4 complex in non-homologous end-joining. | Biochim Biophys Acta Mol Cell Res | 2024 | 39151475 | PubTator, text mining | PubMed |
| Senataxin RNA/DNA helicase promotes replication restart at co-transcriptional R-loops to prevent MUS81-dependent fork degradation. | Nucleic Acids Res | 2024 | 39119900 | PubTator, text mining | PubMed |
| Identification of DNA Repair-related Genes as Biomarkers Reflecting MSI, TMB, and TIL in Colorectal Cancer. | Anticancer Res | 2024 | 39060055 | PubTator, text mining | PubMed |
| Multivalent interactions of the disordered regions of XLF and XRCC4 foster robust cellular NHEJ and drive the formation of ligation-boosting condensates in vitro. | Nat Struct Mol Biol | 2024 | 38898102 | PubTator, text mining | PubMed |
| DNA double-strand break repair capacity and its pathway gene variants predict the risk and prognosis of lung cancer. | Lung Cancer | 2024 | 38805902 | PubTator, text mining | PubMed |
| [Two cases of cytopenia associated with multiple malformations]. | Zhongguo Dang Dai Er Ke Za Zhi | 2024 | 38660906 | PubTator, text mining | PubMed |
| Modulating DNA damage response in uveal melanoma through embryonic stem cell microenvironment. | BMC Cancer | 2024 | 38654216 | PubTator, text mining | PubMed |
| Non-homologous End-joining Genotype, mRNA Expression, and DNA Repair Capacity in Childhood Acute Lymphocytic Leukemia. | Cancer Genomics Proteomics | 2024 | 38423600 | PubTator, text mining | PubMed |
| A di-acetyl-decorated chromatin signature couples liquid condensation to suppress DNA end synapsis. | Mol Cell | 2024 | 38423014 | PubTator, text mining | PubMed |
| DNA-PKcs suppresses illegitimate chromosome rearrangements. | Nucleic Acids Res | 2024 | 38412274 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=5